RHY

1.59%

6.4¢ rhythm biosciences limited

US based company with better results launching world wide, page-15

First 15 Last

Share
Profile

Follow
ShmoShady

554 Posts.

79

28/12/22

22:59

Post #: 65464359
Share

Originally posted by borano: ↑

What rubbish about SimpliPro colon test. Now you are misleading.

I have provided links as to sensitivity and specificity of Simplipro colon test. It was not good enough to get market traction and you believe COLOSTAT will. I think you are dreaming again. I don't mean to disrespect you but don't tell untruths about Simplipro Colon test.

"Clinical data on the SimpliPro Colon test was presented last year at DDW 2016, and showed the test detected all stages of colorectal cancer with 81% sensitivity and 78% specificity." Specificity is not as important as Sensitivity.
With regard to adenomas, Simplipro had a sensitivity of 45%. What makes you think COLOSTAT is far better anyway? It is not been announced as far as I am aware.

So much data of COLOSTAT is not forthcoming. For each stages, adenomas etc etc.

Who cares about Simplipro colon test anyway. Today they are irrelevant. My point about Simplipro was that it is NO LONGER SOLD (TRUE)COULD NOT GET MARKET TRACTION (TRUE)SOLD ALL ITS IP AND ASSETS FOR $1.8 million (TRUE)HAD VERY SIMILAR RESULTS TO COLOSTAT (TRUE)RHY HAS SIMPLIPRO COLON TEST AS A COMPETITOR (NOT TRUE)
Re: Intervenn, who cares at what stage. They will sell a far more superior product than COLOSTAT.
They are not in early stages. (it might look like it). DYOR.

"98 percent sensitivity and 91 percent specificity and advanced adenomas with 98 percent sensitivity and 85 percent specificity."!!!!!!
RHY can't beat this.With regard to your link please provide the transcript as I am not paying for premium information. As a shareholder you should seriously consider it if already haven't.

I FOUND ANOTHER COMPANY IN FULL OPERATION CLIA APPROVED. HAS BEEN GOING FOR 4 YEARS. THE SET UP WILL BLOW YOUR MIND AWAY. DYOR. I WILL SHARE NEXT MONTH SOMETIME.

Let's see what tomorrow brings/

Expand

https://www.appliedproteomics.com

This is a really, really bad website. They should have got a proofreader lmao - “when students opt in for request ‘write an essay for me’ what the heck does that even mean hahaha

Lol if this is the ‘competition’

Last edited by ShmoShady: 28/12/22

RHY Price at posting: 99.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

VUL

Vulcan appoints investment bank and M&A veteran to board

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

MM8

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

ASN

Utah authorities sign off on Anson's lithium extraction plans at Green River

NAM

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

ENV

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

AZY

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

MLS

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

MKG

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

There are more pages in this discussion • 60 more messages in this thread...

First 15 Last

Add RHY (ASX) to my watchlist

(20min delay)
Last 6.4¢		Change 0.001(1.59%)		Mkt cap ! $15.91M

Open	High	Low	Value	Volume
6.4¢	6.4¢	6.4¢	$1.578K	24.65K

Buyers (Bids)

No.	Vol.	Price($)
1	29010	6.4¢

Sellers (Offers)

Price($)	Vol.	No.
6.5¢	31999	2

View Market Depth

No.	Vol.	Price($)
1	29010	0.064
1	3032	0.063
1	16000	0.062
1	50000	0.060
2	38605	0.051

Price($)	Vol.	No.
0.065	31999	2
0.066	107305	1
0.067	195346	2
0.070	1794	1
0.071	10000	1

Last trade - 15.43pm 13/09/2024 (20 minute delay)

RHY (ASX) Chart

US based company with better results launching world wide, page-15

Vulcan appoints investment bank and M&A veteran to board

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Utah authorities sign off on Anson's lithium extraction plans at Green River

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

US based company with better results launching world wide, page-15

Top Stories

Vulcan appoints investment bank and M&A veteran to board

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Utah authorities sign off on Anson's lithium extraction plans at Green River

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News